WebMar 30, 2024 · Precedence Research Predicts, the global oncology market size is expected to worth around US$ 536.01 billion by 2029 from valued at USD 286.04 billion in 2024 and growing at a CAGR of 8.2% from 2024 to 2030. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. Cancer is a leading … WebThe global AI in oncology market size was valued at USD 577.5 million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 35.6% from 2024 to 2030. Artificial intelligence(AI) in oncology helps in faster and accurate diagnosis of cancer which helps to deliver better patient outcomes and this is anticipated to drive the growth of the …
Oncology Companion Diagnostic Market Report, …
WebDec 17, 2024 · According to Precedence Research, the global cancer drugs market size is expected to be worth around US$ 272 billion by 2030 from at US$ 136.2 billion in 2024, growing at a CAGR of 7.2% from 2024 ... WebSep 9, 2024 · Although China represents 18 percent of the global cancer burden, the country makes up more than 50 percent of hepatic cell carcinoma, gastric, and esophageal cancer patients. 1 Detailed perspective on oncology market in China in “Managing … hungry translate spanish
2024-2030 "Oncology Drugs Market" Opportunities and
WebThe global cancer therapy market was valued at approximately USD 158 billion in 2024, and it is expected to witness a revenue of USD 268 billion in 2026, with a CAGR of 9.15% over the forecast period. The COVID-19 pandemic has affected the healthcare systems … WebOct 6, 2024 · The global market for oncology pharmaceuticals should grow from $177.4 billion in 2024 to $313.7 billion by 2026, at a compound annual growth rate (CAGR) of 12.1% for the period of 2024-2026. WebThe global oncology drugs market size was valued at USD 141.33 billion in 2024 and is projected to reach USD 394.24 billion by 2027, exhibiting a CAGR of 11.6% during the forecast period. Oncology is a key driver for the growth of the pharmaceutical industry. It … marty blake and associates